Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bonora

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 1, 1997
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malariaG Di Perri, P Olliaro, S Nardi, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1994
Stability of cefodizime in solution and compatibility with other injectable drugsM Merighi, A Carlotto, L Guella, et al.
Journal of Neurochemistry|January 9, 2026
The Influence of Blood Brain Barrier Permeability on CSF-To-Serum Ratios of Neurobiomarkers in People With HIVJ Cusato, M Antonucci, M Trunfio, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2014
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patientsA Calcagno, S Nozza, M Simiele, et al.
Journal of Medical Virology|October 21, 2025
The Clinical Presentations of Patients With COVID-19 in the Omicron Era: Missed Opportunities in the Antiviral Treatment of SARS-CoV-2 InfectionsG Bartolucci, E Garro, M Mussa, et al.
Journal of Neurovirology|June 29, 2014
Prevalence and predictors of blood-brain barrier damage in the HAART eraA Calcagno, M C Alberione, A Romito, et al.
Journal of Neurovirology|August 7, 2015
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patientsA Calcagno, C Atzori, A Romito, et al.
Antiviral Research|May 28, 2014
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patientsA Calcagno, L Marinaro, S Nozza, et al.
The Journal of Infection|March 14, 2000
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapyG Di Perri, S Vento, R Mazzi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 10, 2016
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus AstrocytosisA Calcagno, A Romito, C Atzori, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 1, 1997
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malariaG Di Perri, P Olliaro, S Nardi, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1994
Stability of cefodizime in solution and compatibility with other injectable drugsM Merighi, A Carlotto, L Guella, et al.
Journal of Neurochemistry|January 9, 2026
The Influence of Blood Brain Barrier Permeability on CSF-To-Serum Ratios of Neurobiomarkers in People With HIVJ Cusato, M Antonucci, M Trunfio, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2014
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patientsA Calcagno, S Nozza, M Simiele, et al.
Journal of Medical Virology|October 21, 2025
The Clinical Presentations of Patients With COVID-19 in the Omicron Era: Missed Opportunities in the Antiviral Treatment of SARS-CoV-2 InfectionsG Bartolucci, E Garro, M Mussa, et al.
Journal of Neurovirology|June 29, 2014
Prevalence and predictors of blood-brain barrier damage in the HAART eraA Calcagno, M C Alberione, A Romito, et al.
Journal of Neurovirology|August 7, 2015
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patientsA Calcagno, C Atzori, A Romito, et al.
Antiviral Research|May 28, 2014
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patientsA Calcagno, L Marinaro, S Nozza, et al.
The Journal of Infection|March 14, 2000
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapyG Di Perri, S Vento, R Mazzi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 10, 2016
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus AstrocytosisA Calcagno, A Romito, C Atzori, et al.
Pageof 11